-
Mashup Score: 0Alexander Miethke, MD: Maralixibat for Progressive Familial Intrahepatic Cholestasis - 7 month(s) ago
The author of the largest clinical trial for pediatric PFIC to date discusses the various benefit maralixibat provides to disease managementr.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0An Overview of Progressive Familial Intrahepatic Cholestasis - 8 month(s) ago
Progressive familial intrahepatic cholestasis (PFIC) is a spectrum of rare genetic diseases that result in reduced bile flow from the liver, also called cholestasis.
Source: CheckRare.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0An Overview of Progressive Familial Intrahepatic Cholestasis - 10 month(s) ago
Progressive familial intrahepatic cholestasis (PFIC) is a spectrum of rare genetic diseases that result in reduced bile flow from the liver, also called cholestasis.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
In a Healio video exclusive, Pam Vig, PhD, highlights new data on Livmarli for the treatment of patients with pruritis due to progressive familial intrahepatic cholestasis and Alagille syndrome, which were presented at EASL Congress. Vig, head of research and development for Mirum Pharmaceuticals Inc., noted Livmarli (maralixibat, Mirum Pharmaceuticals) is currently approved by the FDA for the
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0An Overview of Progressive Familial Intrahepatic Cholestasis - 10 month(s) ago
Progressive familial intrahepatic cholestasis (PFIC) is a spectrum of rare genetic diseases that result in reduced bile flow from the liver, also called cholestasis.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
In a Healio video exclusive, Pam Vig, PhD, highlights new data on Livmarli for the treatment of patients with pruritis due to progressive familial intrahepatic cholestasis and Alagille syndrome, which were presented at EASL Congress. Vig, head of research and development for Mirum Pharmaceuticals Inc., noted Livmarli (maralixibat, Mirum Pharmaceuticals) is currently approved by the FDA for the
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0An Overview of Progressive Familial Intrahepatic Cholestasis - 10 month(s) ago
Progressive familial intrahepatic cholestasis (PFIC) is a spectrum of rare genetic diseases that result in reduced bile flow from the liver, also called cholestasis.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1An Overview of Progressive Familial Intrahepatic Cholestasis - 10 month(s) ago
Progressive familial intrahepatic cholestasis (PFIC) is a spectrum of rare genetic diseases that result in reduced bile flow from the liver, also called cholestasis.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0An Overview of Progressive Familial Intrahepatic Cholestasis - 11 month(s) ago
Progressive familial intrahepatic cholestasis (PFIC) is a spectrum of rare genetic diseases that result in reduced bile flow from the liver, also called cholestasis.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0An Overview of Progressive Familial Intrahepatic Cholestasis - 11 month(s) ago
Progressive familial intrahepatic cholestasis (PFIC) is a spectrum of rare genetic diseases that result in reduced bile flow from the liver, also called cholestasis.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
IBAT inhibitors like maralixibat and odevixibat have benefitted cholestatic disease greater than previously imagined. Now, new data shows significant benefit for patients with #PFIC. Our study author interview: #NASPGHAN23 #hepatology @CincyChildrens https://t.co/2ZKcoEkt2X https://t.co/ZnyyaKLRtx